(Q42827073)

8 November 2017

title

Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells (English)

1 reference

8 November 2017

0 references

1 reference

8 November 2017

1 reference

8 November 2017

1 reference

8 November 2017

Can Küçük

0 references

Timothy McKeithan

0 references

Sirpa Leppä

0 references

Philippe Gaulard

0 references

Wing C Chan

1 reference

8 November 2017

Bei Jiang

1 reference

8 November 2017

Xiaozhou Hu

1 reference

8 November 2017

Wenyan Zhang

1 reference

8 November 2017

John K C Chan

1 reference

8 November 2017

Wenming Xiao

1 reference

8 November 2017

Nathan Lack

1 reference

8 November 2017

John C Williams

1 reference

8 November 2017

Kendra N Avery

1 reference

8 November 2017

Pınar Kavak

1 reference

8 November 2017

Anna Scuto

1 reference

8 November 2017

Emel Sen

1 reference

8 November 2017

Lou Staudt

1 reference

8 November 2017

Javeed Iqbal

1 reference

8 November 2017

Weiwei Zhang

1 reference

8 November 2017

Adam Cornish

1 reference

8 November 2017

Qunpei Yang

1 reference

8 November 2017

Hong Sun

1 reference

8 November 2017

Francesco d'Amore

1 reference

8 November 2017

Weiping Liu

1 reference

8 November 2017

Kai Fu

1 reference

8 November 2017

language of work or name

English

0 references

publication date

14 January 2015

1 reference

8 November 2017

published in

Nature Communications

1 reference

8 November 2017

1 reference

8 November 2017

page(s)

6025

1 reference

describes a project that uses

8 November 2017

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

The 2008 WHO classification of lymphomas: implications for clinical practice and translational research.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Natural killer-cell malignancies: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Frequent mutations of Fas gene in nasal NK/T cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

STATs in cancer inflammation and immunity: a leading role for STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Rare occurrence of JAK3 mutations in natural killer cell neoplasms in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Identification of STAT5A and STAT5B target genes in human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Comprehensive review of JAK inhibitors in myeloproliferative neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

STAT3 mutations are present in aggressive B-cell lymphomas including a subset of diffuse large B-cell lymphomas with CD30 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Somatic STAT3 mutations in large granular lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

An integrated map of genetic variation from 1,092 human genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Fast and accurate short read alignment with Burrows-Wheeler transform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

A framework for variation discovery and genotyping using next-generation DNA sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

PRDM1 is a tumor suppressor gene in natural killer cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Comparative protein modelling by satisfaction of spatial restraints

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

ClusPro: an automated docking and discrimination method for the prediction of protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

MolDock: a new technique for high-accuracy molecular docking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Identification and grafting of a unique peptide-binding site in the Fab framework of monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

7 January 2021

Identification of HIF2α as an important STAT5 target gene in human hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

7 January 2021

Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

7 January 2021

STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

7 January 2021

Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7025

7 January 2021

Identifiers

DOI

10.1038/NCOMMS7025

1 reference

release_fageivad75d27feox4ft3m5y24

8 November 2017

0 references

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fageivad75d27feox4ft3m5y24

24 November 2022

mapped directly with Wikidata item

1 reference